Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.47 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.47 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.47 |
| ▸ | TTR | P02766 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | CALM1 | P0DP23 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31443776 | 1.00 | CYP3A4 (0.50) | CYP3A4PTGS2ALOX5CYP1A1CYP1B1 | |
| SCHEMBL309832 | 0.82 | ALDH1A1 (0.59) | CYP3A4PTGS2ALOX5CYP1A1CYP1B1 | |
| SCHEMBL202288 | 0.82 | ALDH1A1 (0.69) | CYP3A4PTGS2ALOX5CYP1A1CYP1B1 | |
| SCHEMBL233829 | 0.82 | ALDH1A1 (0.69) | CYP3A4PTGS2ALOX5CYP1A1CYP1B1 | |
| Flamenol SCHEMBL69428 | 0.82 | CYP3A4 (0.62) | CYP3A4PTGS2ALOX5CYP1A1CYP1B1 | |
| SCHEMBL29051042 | 0.80 | GABRA1 (0.56) | CYP3A4PTGS2ALOX5CYP1A1CYP1B1 | |
| Flamenol SCHEMBL3190965 | 0.79 | CYP3A4 (0.59) | CYP3A4PTGS2ALOX5CYP1A1CYP1B1 | |
| SCHEMBL3966378 | 0.79 | ALDH1A1 (0.65) | CYP3A4PTGS2ALOX5CYP1A1CYP1B1 | |
| SCHEMBL2999328 | 0.79 | ALDH1A1 (0.65) | CYP3A4PTGS2ALOX5CYP1A1CYP1B1 | |
| SCHEMBL17204044 | 0.76 | GABRA1 (0.39) | CYP3A4PTGS2ALOX5ALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116478199-A | Bimetallic catalyst and preparation method thereof, and preparation method of high molecular weight olefin polymer | 万华化学集团股份有限公司 | 2023-07-25 | — | — | CN | claimed |
| US-10029992-B2 | Diaminotriazine compounds and their use as herbicides | BASF SE (DE) | 2018-07-24 | — | — | US | claimed |
| EP-3134391-A1 | DIAMINOTRIAZINE COMPOUNDS AND THEIR USE AS HERBICIDES | BASF SE (DE) | 2017-03-01 | — | — | EP | claimed |
| US-20170044114-A1 | Diaminotriazine compounds and their use as herbicides | BASF SE (DE) | 2017-02-16 | — | — | US | claimed |
| WO-2015162166-A1 | DIAMINOTRIAZINE COMPOUNDS AND THEIR USE AS HERBICIDES | BASF SE (DE) | 2015-10-29 | — | — | WO | claimed |
| US-20050043369-A1 | Bactericidal antimicrobial methods and compositions for use in treating gram positive infections | PROTEZ PHARMACEUTICALS INC. (US) | 2005-02-24 | — | — | US | claimed |
| US-20030225126-A1 | Bactericidal antimicrobial methods and compositions for use in treating gram positive infections | INFLUX, INC. | 2003-12-04 | — | — | US | claimed |
| EP-1296688-A2 | BACTERICIDAL ANTIMICROBIAL METHODS AND COMPOSITIONS FOR USE IN TREATING GRAM POSITIVE INFECTIONS COMPRISING AN ANTIBIOTIC POTENTIATOR HAVING ACYL HYDRAZIDE, OXY AMIDE OR 8-HYDROXY QUINOLINE STRUCTURE | Influx, Inc. (US) | 2003-04-02 | — | — | EP | claimed |
| WO-2001070213-A2 | BACTERICIDAL ANTIMICROBIAL METHODS AND COMPOSITIONS FOR USE IN TREATING GRAM POSITIVE INFECTIONS COMPRISING AN ANTIBIOTIC POTENTIATOR HAVING ACYL HYDRAZIDE OXY AMIDE OR 8-HYDROXY QUINOLINE STRUCTURE | INFLUX, INC. (US) | 2001-09-27 | — | — | WO | claimed |
| EP-4747247-A1 | NOVEL FATTY ACID AMIDE HYDROLASE MODULATORS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF | Apogee Pharmaceuticals, Inc. (CA) | 2026-05-27 | — | — | EP | disclosed |
| EP-4735423-A1 | KV7 MODULATORS | Saniona A/S (DK) | 2026-05-06 | — | — | EP | disclosed |
| US-12459883-B2 | Substituted hydroxystilbene compounds and derivatives synthesis and uses thereof | Kynan Duke IP, LLC (US) | 2025-11-04 | — | — | US | disclosed |
| US-12410137-B2 | Fatty acid amide hydrolase modulators, compositions comprising the same and uses thereof | APOGEE PHARMACEUTICALS, INC. (CA) | 2025-09-09 | — | — | US | disclosed |
| US-20250129027-A1 | FATTY ACID AMIDE HYDROLASE MODULATORS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF | APOGEE PHARMACEUTICALS, INC. (CA) | 2025-04-24 | — | — | US | disclosed |
| WO-2007034325-A1 | CARBOXAMIDE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS | PFIZER LIMITED (GB) | 2007-03-29 | — | — | WO | disclosed |
| US-20050043369-A1 | Bactericidal antimicrobial methods and compositions for use in treating gram positive infections | PROTEZ PHARMACEUTICALS INC. (US) | 2005-02-24 | — | — | US | disclosed |
| US-20030225126-A1 | Bactericidal antimicrobial methods and compositions for use in treating gram positive infections | INFLUX, INC. | 2003-12-04 | — | — | US | disclosed |
| EP-1296688-A2 | BACTERICIDAL ANTIMICROBIAL METHODS AND COMPOSITIONS FOR USE IN TREATING GRAM POSITIVE INFECTIONS COMPRISING AN ANTIBIOTIC POTENTIATOR HAVING ACYL HYDRAZIDE, OXY AMIDE OR 8-HYDROXY QUINOLINE STRUCTURE | Influx, Inc. (US) | 2003-04-02 | — | — | EP | disclosed |
| WO-2001070213-A2 | BACTERICIDAL ANTIMICROBIAL METHODS AND COMPOSITIONS FOR USE IN TREATING GRAM POSITIVE INFECTIONS COMPRISING AN ANTIBIOTIC POTENTIATOR HAVING ACYL HYDRAZIDE OXY AMIDE OR 8-HYDROXY QUINOLINE STRUCTURE | INFLUX, INC. (US) | 2001-09-27 | — | — | WO | disclosed |
| US-3959388-A | Preparation of phloroglucinol or its monomethyl ether | ANDENO B.V. (NL) | 1976-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030225126-A1 | Bactericidal antimicrobial methods and compositions for use in treating gram positive infections | NAAA, TLR8, OPA1 | CYP3A4 2103/4885PTGS2 1384/4885ALOX5 817/4885 |
| US-20250129027-A1 | FATTY ACID AMIDE HYDROLASE MODULATORS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF | FAAH, FAAH2, MGLL | CYP3A4 654/4885PTGS2 249/4885ALOX5 20/4885 |
| US-12410137-B2 | Fatty acid amide hydrolase modulators, compositions comprising the same and uses thereof | FAAH, FAAH2, MGLL | CYP3A4 654/4885PTGS2 249/4885ALOX5 20/4885 |
| US-10029992-B2 | Diaminotriazine compounds and their use as herbicides | NR4A3, CBR3, RCOR3 | CYP3A4 2369/4885PTGS2 2846/4885ALOX5 4204/4885 |
| US-12459883-B2 | Substituted hydroxystilbene compounds and derivatives synthesis and uses thereof | CYP8B1, HSD11B1, HSD11B2 | CYP3A4 119/4885PTGS2 213/4885ALOX5 161/4885 |
| US-20050043369-A1 | Bactericidal antimicrobial methods and compositions for use in treating gram positive infections | NAAA, TLR8, OPA1 | CYP3A4 2103/4885PTGS2 1384/4885ALOX5 817/4885 |
| US-20170044114-A1 | Diaminotriazine compounds and their use as herbicides | NR4A3, CBR3, RCOR3 | CYP3A4 2402/4885PTGS2 2869/4885ALOX5 4230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.